Breadcrumb Navigation

Amyloid PET (Neurodegeration)

Vizamyl® is a radioactive diagnostic agent used for positron emission tomography (PET) imaging of the brain in order to estimate the β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD) or other causes of cognitive decline.

Pathologically increased amyloid deposition in the gray matter in a patient with suspected Alzheimer's disease.
Pathologically increased amyloid deposition in the gray matter in a patient with suspected Alzheimer’s disease.

Indications

The following indication is reimbursed by the health insurance:

  • Referral by a specialist FMH in geriatrics, neurology or psychiatry.
  • Minimal score > 10
  • Duration of the disease < 5 years
  • Patient < 80
  • No PET or SPECT examinations to date
Details see PDF, page 105ff

Responsible doctors

Martin Hüllner, PD Dr. med.

Senior Attending Physician, Department of Nuclear Medicine
Deputy Clinic Director, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine
Diagnostic Neuroradiologist, Department of Nuclear Medicine

Specialties: Oncological, neurological and musculoskeletal imaging
Tel. +41 44 255 25 80

Lars Husmann, Prof. Dr. med.

Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine

Specialties: PET/CT Imaging
Tel. +41 43 253 87 99

David Kenkel, Dr. med.

Attending Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine

Specialties: Oncological imaging (PET, SPECT, CT, MRI)

Cäcilia Mader, Dr. med.

Senior Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine
Neuroradiologist, Department of Nuclear Medicine

Specialties: Oncological, neurological and musculoskeletal hybrid imaging
Tel. +41 43 253 88 02

Alexander Maurer, Dr. med.

Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine

Specialties: Oncologic imaging, Hybrid imaging of prostate cancer
Tel. +41 43 253 88 09

Michael Messerli, PD Dr. med.

Attending Physician, Department of Nuclear Medicine
Nuclear Medicine Physician, Department of Nuclear Medicine
Radiologist, Department of Nuclear Medicine

Specialties: Hybrid imaging of oncological diseases (PET, SPECT, CT, MRI)
Tel. +41 43 253 88 03

For patients

As a patient, you cannot register directly for a consultation. Please have your family doctor, specialist refer you. If you have any questions, please use our contact form.

Tel. +41 44 255 35 55

For referring physicians

Simply assign your patient via registration form.

Tel. +41 44 255 35 55

Medical information hotline: 08.00-18.00 o’clock: +41 44 255 15 02